Ashley Crouch, Mariesa Le, C. Rogers
Aug 11, 2021
Citations
0
Influential Citations
2
Citations
Quality indicators
Journal
Transplant Infectious Disease
Abstract
Famciclovir is a recommended option for herpes simplex virus (HSV) and varicella‐zoster virus (VZV) prophylaxis in cytomegalovirus (CMV) low‐risk solid organ transplant (SOT) recipients in current guidelines; however there is currently no data evaluating its use in SOT recipients. We conducted a multicenter provider survey on antiviral prophylaxis in CMV low‐risk SOT recipients and evaluated the efficacy and safety of once daily famciclovir antiviral prophylaxis.